2025-01-012025-12-312025-12-31false03541703Collinson Grant Group Limited2026-08-14falseiso4217:GBPxbrli:pure035417032024-12-31035417032025-12-31035417032025-01-012025-12-31035417032023-12-31035417032024-12-31035417032024-01-012024-12-3103541703bus:SmallEntities2025-01-012025-12-3103541703bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3103541703bus:FullAccounts2025-01-012025-12-3103541703bus:PrivateLimitedCompanyLtd2025-01-012025-12-3103541703core:WithinOneYear2025-12-3103541703core:AfterOneYear2025-12-3103541703core:WithinOneYear2024-12-3103541703core:AfterOneYear2024-12-3103541703core:ShareCapital2025-12-3103541703core:SharePremium2025-12-3103541703core:RevaluationReserve2025-12-3103541703core:OtherReservesSubtotal2025-12-3103541703core:RetainedEarningsAccumulatedLosses2025-12-3103541703core:ShareCapital2024-12-3103541703core:SharePremium2024-12-3103541703core:RevaluationReserve2024-12-3103541703core:OtherReservesSubtotal2024-12-3103541703core:RetainedEarningsAccumulatedLosses2024-12-3103541703core:LandBuildings2025-12-3103541703core:PlantMachinery2025-12-3103541703core:Vehicles2025-12-3103541703core:FurnitureFittings2025-12-3103541703core:OfficeEquipment2025-12-3103541703core:NetGoodwill2025-12-3103541703core:IntangibleAssetsOtherThanGoodwill2025-12-3103541703core:ListedExchangeTraded2025-12-3103541703core:UnlistedNon-exchangeTraded2025-12-3103541703core:LandBuildings2024-12-3103541703core:PlantMachinery2024-12-3103541703core:Vehicles2024-12-3103541703core:FurnitureFittings2024-12-3103541703core:OfficeEquipment2024-12-3103541703core:NetGoodwill2024-12-3103541703core:IntangibleAssetsOtherThanGoodwill2024-12-3103541703core:ListedExchangeTraded2024-12-3103541703core:UnlistedNon-exchangeTraded2024-12-3103541703core:LandBuildings2025-01-012025-12-3103541703core:PlantMachinery2025-01-012025-12-3103541703core:Vehicles2025-01-012025-12-3103541703core:FurnitureFittings2025-01-012025-12-3103541703core:OfficeEquipment2025-01-012025-12-3103541703core:NetGoodwill2025-01-012025-12-3103541703core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3103541703core:ListedExchangeTraded2025-01-012025-12-3103541703core:UnlistedNon-exchangeTraded2025-01-012025-12-3103541703core:MoreThanFiveYears2025-01-012025-12-3103541703core:Non-currentFinancialInstruments2025-12-3103541703core:Non-currentFinancialInstruments2024-12-3103541703dpl:CostSales2025-01-012025-12-3103541703dpl:DistributionCosts2025-01-012025-12-3103541703core:LandBuildings2025-01-012025-12-3103541703core:PlantMachinery2025-01-012025-12-3103541703core:Vehicles2025-01-012025-12-3103541703core:FurnitureFittings2025-01-012025-12-3103541703core:OfficeEquipment2025-01-012025-12-3103541703dpl:AdministrativeExpenses2025-01-012025-12-3103541703core:NetGoodwill2025-01-012025-12-3103541703core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3103541703dpl:GroupUndertakings2025-01-012025-12-3103541703dpl:ParticipatingInterests2025-01-012025-12-3103541703dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3103541703core:ListedExchangeTraded2025-01-012025-12-3103541703dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3103541703core:UnlistedNon-exchangeTraded2025-01-012025-12-3103541703dpl:CostSales2024-01-012024-12-3103541703dpl:DistributionCosts2024-01-012024-12-3103541703core:LandBuildings2024-01-012024-12-3103541703core:PlantMachinery2024-01-012024-12-3103541703core:Vehicles2024-01-012024-12-3103541703core:FurnitureFittings2024-01-012024-12-3103541703core:OfficeEquipment2024-01-012024-12-3103541703dpl:AdministrativeExpenses2024-01-012024-12-3103541703core:NetGoodwill2024-01-012024-12-3103541703core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3103541703dpl:GroupUndertakings2024-01-012024-12-3103541703dpl:ParticipatingInterests2024-01-012024-12-3103541703dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3103541703core:ListedExchangeTraded2024-01-012024-12-3103541703dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3103541703core:UnlistedNon-exchangeTraded2024-01-012024-12-3103541703core:NetGoodwill2025-12-3103541703core:IntangibleAssetsOtherThanGoodwill2025-12-3103541703core:LandBuildings2025-12-3103541703core:PlantMachinery2025-12-3103541703core:Vehicles2025-12-3103541703core:FurnitureFittings2025-12-3103541703core:OfficeEquipment2025-12-3103541703core:AfterOneYear2025-12-3103541703core:WithinOneYear2025-12-3103541703core:ListedExchangeTraded2025-12-3103541703core:UnlistedNon-exchangeTraded2025-12-3103541703core:ShareCapital2025-12-3103541703core:SharePremium2025-12-3103541703core:RevaluationReserve2025-12-3103541703core:OtherReservesSubtotal2025-12-3103541703core:RetainedEarningsAccumulatedLosses2025-12-3103541703core:NetGoodwill2024-12-3103541703core:IntangibleAssetsOtherThanGoodwill2024-12-3103541703core:LandBuildings2024-12-3103541703core:PlantMachinery2024-12-3103541703core:Vehicles2024-12-3103541703core:FurnitureFittings2024-12-3103541703core:OfficeEquipment2024-12-3103541703core:AfterOneYear2024-12-3103541703core:WithinOneYear2024-12-3103541703core:ListedExchangeTraded2024-12-3103541703core:UnlistedNon-exchangeTraded2024-12-3103541703core:ShareCapital2024-12-3103541703core:SharePremium2024-12-3103541703core:RevaluationReserve2024-12-3103541703core:OtherReservesSubtotal2024-12-3103541703core:RetainedEarningsAccumulatedLosses2024-12-3103541703core:NetGoodwill2023-12-3103541703core:IntangibleAssetsOtherThanGoodwill2023-12-3103541703core:LandBuildings2023-12-3103541703core:PlantMachinery2023-12-3103541703core:Vehicles2023-12-3103541703core:FurnitureFittings2023-12-3103541703core:OfficeEquipment2023-12-3103541703core:AfterOneYear2023-12-3103541703core:WithinOneYear2023-12-3103541703core:ListedExchangeTraded2023-12-3103541703core:UnlistedNon-exchangeTraded2023-12-3103541703core:ShareCapital2023-12-3103541703core:SharePremium2023-12-3103541703core:RevaluationReserve2023-12-3103541703core:OtherReservesSubtotal2023-12-3103541703core:RetainedEarningsAccumulatedLosses2023-12-3103541703core:AfterOneYear2025-01-012025-12-3103541703core:WithinOneYear2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3103541703core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3103541703core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3103541703core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3103541703core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3103541703core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3103541703core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3103541703core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3103541703core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3103541703core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3103541703core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3103541703core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3103541703bus:Director12025-01-012025-12-31035417031bus:Director12024-12-31035417031bus:Director12025-01-012025-12-31035417031bus:Director12025-12-31035417032024-12-31035417032025-01-012025-12-31035417032025-12-31

Collinson Grant Group Limited

Registered Number
03541703
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

Collinson Grant Group Limited
Company Information
for the year from 1 January 2025 to 31 December 2025

Director

A Collinson

Company Secretary

P Leary

Registered Address

Ryecroft
Aviary Road
Worsley
M28 2WF

Registered Number

03541703 (England and Wales)
Collinson Grant Group Limited
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Investments3902900
902900
Current assets
Debtors4125,610118,051
Cash at bank and on hand3722,229,686
125,9822,347,737
Creditors amounts falling due within one year5-(2,021,316)
Net current assets (liabilities)125,982326,421
Total assets less current liabilities126,884327,321
Net assets126,884327,321
Capital and reserves
Called up share capital900900
Profit and loss account125,984326,421
Shareholders' funds126,884327,321
The financial statements were approved and authorised for issue by the Director on 14 August 2026, and are signed on its behalf by:
A Collinson
Director
Registered Company No. 03541703
Collinson Grant Group Limited
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
Going concern
The director has assessed the company's position, including the recoverability of amounts due from group undertakings, and has a reasonable expectation that the company has adequate resources to continue in operational existence for at least twelve months from the date of approval of these financial statements. The financial statements have therefore been prepared on the going concern basis.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. There are no significant judgements or estimates made by management that have a significant effect on the amounts recognised in the financial statements.
Interest income
Interest income is recognised using the effective interest rate method.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20252024
Average number of employees during the year00
3.Fixed asset investments
The company holds investments in the following subsidiary undertakings: Collinson Grant Limited, a company registered in England and Wales with its registered office at Ryecroft, Aviary Road, Worsley, Manchester, M28 2WF. The company holds 100% of the ordinary share capital. Colt Brands Limited, a company registered in England and Wales with its registered office at Bucklow House, Mereside Road, Mere, Knutsford, Cheshire, WA16 6QR. The company holds 75% of the ordinary share capital. Collinson Grant Inc, a company incorporated in the United States of America. The company holds 100% of the ordinary share capital. The company has taken advantage of the exemption in paragraph 3 of Schedule 2 to the Small Companies and Groups (Accounts and Directors' Report) Regulations 2008 not to disclose the aggregate capital and reserves and results of its subsidiary undertakings.

Investments in groups1

Total

££
Cost or valuation
At 01 January 25900900
Additions22
At 31 December 25902902
Net book value
At 31 December 25902902
At 31 December 24900900

Notes

1Investments in group undertakings and participating interests
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables-12,538
Other debtors125,61091,478
Prepayments and accrued income-14,035
Total125,610118,051
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-18,240
Other creditors-2,003,076
Total-2,021,316
6.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
A Collinson086,000086,000
Repaid in full on 20th March 2026
086,000086,000
7.Related party transactions
The company has taken advantage of the exemption available under FRS102 Section 1A Small Entities not to disclose transactions with its wholly owned subsidiaries and with companies that are under common control.
8.Controlling party
A Collinson is the sole shareholder of Collinson Grant Group Limited and is considered to be the ultimate controlling party.